Agenda for Day 3 – Thursday, March 25, 2027Thursday, 25 March 2027 - EST/EDT (Eastern Daylight, GMT-4)

• Navigate critical resource allocation decisions through candid peer dialogue on the daily dilemmas foundation leaders face—determining optimal award amounts when demand outpaces donations, implementing waitlists versus tightening eligibility criteria when funds near depletion and expanding outreach to underserved populations without accelerating fund exhaustion that compromises long-term viability

• Measure true charitable impact using comprehensive retrospective analysis that examines what patient out-of-pocket costs really look like across insurance types, therapeutic areas, and demographics, revealing whether current donation models are keeping pace with rising healthcare costs and what percentage of total patient financial burden charitable assistance realistically addresses after a decade of escalating demands

This session brings a lived patient perspective into the conversation on how patient assistance and access programs are experienced day to day.

• Understand what clear, patient-centered communication looks like from the patient's side
• Explore how to ask about practical barriers to access without making assumptions
• Assess how organizations can meaningfully include patient perspectives in program design and decision-making

• Explore groundbreaking patient journey models that address the unique logistical, financial and clinical complexities of accessing cell and gene therapies—from diagnosis through treatment and long-term follow-up care
• Identify key stakeholders and support systems who are actively removing barriers and expanding access to these life-changing therapies
• Discover scalable solutions and emerging programs that are successfully increasing the number of patients who can receive cell and gene therapies, including financial assistance initiatives, care coordination platforms and innovative reimbursement models

• Synthesize critical insights from the conference's most pressing discussions—manufacturer donation dilemmas, foundation sustainability challenges, eligibility tightening strategies, and vendor transitions—into a cohesive understanding of how current industry pressures and decisions ultimately impact the patients these programs were designed to serve

• Confront the trajectory of patient assistance programs through honest dialogue about what happens when funds deplete faster than donations arrive, when eligibility criteria become so restrictive that vulnerable patients fall through the cracks, and when the cumulative effect of cost-containment decisions across manufacturers and foundations leaves patients without access to life-saving treatments

• Chart a collective path forward by identifying actionable strategies, collaborative opportunities, and advocacy priorities that can reshape the patient assistance landscape in 2027 and beyond, ensuring programs evolve to meet growing demand while preserving their fundamental mission of helping patients who have nowhere else to turn

Join your peers for Access USA 2027's most candid session yet, alongside all ecosystem stakeholders. In this interactive closing conversation, join focused roundtables organized by vendor type – PAP providers, Hub services, AI solutions, specialty pharmacy partners and more.

Whether you're evaluating new partnerships, troubleshooting existing relationships or simply curious about what others are experiencing, this peer-to-peer exchange offers the unvarnished insights you won't find in any RFP response.

Come ready to listen, share and leave with actionable intelligence from those who've been in the trenches.